Skip to content

Tuberculosis Gene Mutation Detection (Tuberculosis Genomic Testing)

Published: August 9, 2026Updated: August 16, 2026

This test checks for specific genetic mutations linked to drug-resistant tuberculosis (TB). It helps determine if TB bacteria are resistant to certain medications, guiding treatment decisions.

Quick summary

["Helps tailor TB treatment to avoid ineffective or harmful drugs."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
107204-0
Short code
TCRG gene Tube B Spec
Synonyms
TCRG gene Tube B Spec
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
molgen
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Your healthcare provider may order this test to help investigate symptoms, screen for certain health conditions, monitor an issue you already have, or check how well a treatment is working. The results give your care team useful information to guide the next steps in your care and help them make informed decisions with you.

Your healthcare provider may recommend this test if you have suspected tuberculosis, especially if you’ve been exposed to drug-resistant TB or if traditional TB treatments haven’t worked as expected. It’s also used in certain clinical trials or research settings to monitor genetic resistance patterns.

This test works by analyzing a sample collected from your body using established laboratory methods. Trained laboratory professionals process the sample and measure specific markers, and those values are then compared with standard reference ranges so your provider can interpret what the results may mean for your overall health.

The test analyzes a small sample of your sputum (a cough fluid) or other TB-related bodily fluid to detect mutations in the *ISG11* or *katG* genes, which are associated with drug resistance. Advanced lab techniques, such as next-generation sequencing, identify these genetic changes.

A sample is typically collected at a clinic, laboratory, or other testing site by trained staff. Depending on the type of test, you may be asked to fast for a certain period, avoid certain foods or medications, or drink plenty of water ahead of time. Always follow the specific instructions your provider gives you, and mention any medications or supplements you take.

You’ll provide a sample (like sputum) during a coughing session or through a lab-provided collection kit. The sample is then processed and tested for genetic markers without needing blood or urine.

Most collection procedures are quick and routine. If a blood sample is drawn, you may feel a brief pinch or mild discomfort, but serious problems are uncommon. After the sample is collected, you can usually return to your normal activities right away, although you may be asked to apply light pressure to the site or keep a small bandage in place for a short time.

Results typically take 1–2 weeks. Your provider will discuss findings with you, including whether drug-resistant TB is suspected and how it may affect your treatment plan.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Short name

Tuberculosis Genomic Screening

Frequently asked questions

This test is critical for managing tuberculosis, especially in cases where standard antibiotics fail. Identifying genetic resistance allows providers to switch to more effective drugs sooner, reducing treatment failure and potential spread of drug-resistant strains.
How long does it usually take to receive my results after this test has been completed?
Results are usually available within 1 to 2 weeks after your sample is processed. Your healthcare provider will contact you to review the findings and discuss next steps.
Is this test typically covered by health insurance, or will I need to pay for it out of pocket?
Coverage depends on your insurance plan and clinical indication. Some plans may require prior authorization, especially if the test is part of a research or specialized treatment protocol. Check with your insurer or provider for details.
If drug-resistant TB is confirmed, your provider will adjust your treatment plan to use medications that target the resistant mutations. Follow-up testing may be needed to monitor response and adjust therapy as needed. This process ensures you receive the most effective care.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy